Analyst Ratings for Cardiome Pharma (CRME)

CRME Rating Summary

CRME Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CRME
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $7.08 (+157.6%) * Over Last 12-Mos
Rating Score: 6.4 / 10   Percentile Rank: 72%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
12/22/2016 Leerink Partners New Coverage Outperform
(N/A)
4.75
(N/A)
2.65 2.75 3.77% Details
6/1/2016 H.C. Wainwright New Coverage Buy
(N/A)
9.50
(N/A)
4.68 2.75 -41.24% Details
Like CRME Ratings? Also take a look at AGN

CRME Ratings News